4 Apr
Rooms are still available at two nearby hotels.
Residence Inn Indianapolis Downtown on the Canal
350 W New York Street
Indianapolis, Indiana 46202
Telephone: 1.317.822.0840
Courtyard Indianapolis Downtown
501 West Washington Street
Indianapolis, Indiana 46204
Phone: 1-317-635-4443
Click on this link if you would like to view a map of where these hotels and the GLDMDG meeting site are located.
24 Mar
Online registration for the 3rd annual meeting is now available. You can register to attend the meeting at the SPORG.com website.
21 Mar
Meeting attendees have the opportunity to present posters at the upcoming meeting. Poster information will be collected during the online registration process.
Poster setup will take place on May 1st between 10:00 AM and 11:00 AM. Attendees will be able to view the posters during breaks and during the evening mixer. Authors are asked to spend one hour during the mixer (5:00 PM - 6:00 PM) at their posters to answer questions. Posters must be completely dismounted at the conclusion of the meeting on May 2nd.
The poster board is 8 feet wide by 4 feet high so the mounting surface (usable space) is 7′10″ wide by 3′10″ high. The Great Lakes DMDG committee will supply the poster boards, poster numbers and push pins to aid in the poster setup.
26 Feb
Below is a tentative schedule of the 3rd annual meeting. Click here to download the schedule as an Adobe Acrobat (.pdf) file.
| Thursday, May 1, 2008 | |
|---|---|
| 10:00 | Registration/Coffee/Poster Setup (Conference Center Foyer) |
| 11:00 | Welcome |
| 11:10 | The evolution of drug metabolism: The gatekeeper for therapeutics. Pat Murphy, Butler University. |
| 11:50 | Is ABCG2 (Breast Cancer Resistance Protein; BCRP) the Next P-glycoprotein? Tom Raub, Lilly Research Laboratories. |
| 12:30 | Lunch, poster viewing and sponsor booths |
| 2:00 | Nuclear receptors mediate the cross-talk between endogenous pathways and drug metabolism. Urs Meyer, University of Basel. |
| 2:40 | Intracrine regulation of hepatic cytochrome P450 expression. Tom Kocarek, Wayne State University. |
| 3:20 | Break (refreshments in the Lobby) |
| 3:40 | The chemistry and biological consequences of protein modification by reactive aldehydes. Larry Marnett, Vanderbilt University. |
| 4:20 | Inter-species differences in carboxylesterase activity and expression: Impact on activation and pharmacokinetics of prodrugs. Everett Perkins, Lilly Research Laboratories. |
| 5:00 | Poster session (author available), sponsor booths and mixer |
| 7:00 | Dinner (First Floor Ballroom) |
| Friday, May 2, 2008 | |
|---|---|
| 7:30 | Business meeting |
| 8:00 | Coffee |
| 9:00 | Inhibition of multiple hepatobiliary transporters by a novel kinase inhibitor contributes to liver toxicity in multiple species. Scott Daniels, Pfizer. |
| 9:35 | Combining novel structure-based and ligand-based computational approaches to model cytochrome P450-ligand interaction. Marcus Lill, Purdue University. |
| 10:10 | Break |
| 10:30 | Non-P450 mediated metabolism: Carbonyl reduction. Yanbin Lao, Abbott. |
| 11:05 | Quinoids formed from selective estrogen receptor modulators (SERMs): Biological consequences? Judy Bolton, University of Illinois. |
| 11:40 | Closing Remarks |